Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Reviva Pharmaceuticals Holdings ( (RVPH) ) has shared an announcement.
Reviva Pharmaceuticals Holdings, which is listed on the Nasdaq Capital Market, has disclosed heightened risks related to maintaining its stock exchange listing after failing to meet Nasdaq’s minimum bid price requirement of $1.00 per share. On May 13, 2025, the company received a non-compliance notice, and after not regaining compliance by the initial November 10, 2025 deadline and being deemed ineligible for a second standard compliance period, it faced a delisting determination on November 11, 2025. A subsequent hearing before a Nasdaq Hearings Panel on January 8, 2026 resulted in an exception allowing Reviva until March 27, 2026 to restore its share price, potentially through measures such as a reverse stock split, though the company warns such an action could hurt share price performance, liquidity, and overall market capitalization. Reviva cautions that failure to regain or maintain compliance could lead to delisting, which in turn could materially reduce stock liquidity and price, impair its ability to raise capital on acceptable terms, and undermine confidence among investors and business partners.
The most recent analyst rating on (RVPH) stock is a Sell with a $0.33 price target. To see the full list of analyst forecasts on Reviva Pharmaceuticals Holdings stock, see the RVPH Stock Forecast page.
Spark’s Take on RVPH Stock
According to Spark, TipRanks’ AI Analyst, RVPH is a Neutral.
The score is primarily pressured by weak financial performance (no revenue, persistent losses and cash burn, and funding/dilution risk) and bearish technicals (below key moving averages with negative MACD). Corporate events further increase financing and execution risk, while valuation signals are not informative due to negative earnings and no dividend.
To see Spark’s full report on RVPH stock, click here.
More about Reviva Pharmaceuticals Holdings
Average Trading Volume: 6,285,721
Technical Sentiment Signal: Sell
Current Market Cap: $38.87M
See more insights into RVPH stock on TipRanks’ Stock Analysis page.